Showing 151-160 of 1827 results for "".
Lipid Management & Smoking Cessation
https://practicalneurology.com/diseases-diagnoses/stroke/lipid-management-smoking-cessation/31863/High cholesterol and smoking are modifiable factors to prevent secondary stroke.The Bidirectional Relationship Between Sleep Disorders and Stroke
https://practicalneurology.com/diseases-diagnoses/sleep/the-bidirectional-relationship-between-sleep-disorders-and-stroke/32191/Sleep disorders and stroke share comorbid and interrelated risk factors that may influence functional outcomes and stroke recovery.Rehabilitation for People with Movement Disorders
https://practicalneurology.com/diseases-diagnoses/movement-disorders/rehabilitation-for-people-with-movement-disorders/32043/There are 2 main objectives to neurologic rehabilitation for people with movement disorders: 1) to maintain body structure and 2) to maximize functional skills.Molecular Imaging Biomarkers in Dementia
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/molecular-imaging-biomarkers-in-dementia/31729/Amyloid and tau PET imaging aids evaluation of patients suspected of having Alzheimer disease or other dementias.Diagnosis of Chronic Inflammatory Demyelinating Polyneuropathy
https://practicalneurology.com/diseases-diagnoses/neuromuscular/diagnosis-of-chronic-inflammatory-demyelinating-polyneuropathy/32112/Due to the heterogeneous presentation of this complex disease, diagnosis is not always straightforward, and proper interpretation of clinical and diagnostic data is crucial to avoid misdiagnosis.Brain Imaging in Differential Diagnosis of Dementia
https://practicalneurology.com/diseases-diagnoses/imaging-testing/brain-imaging-in-differential-diagnosis-of-dementia/31533/Imaging biomarkers hold the promise of earlier diagnosis that may lead to more effective treatment.Toward Precision Medicine for Genetic Epilepsies: Glucose Transporter Type 1 Deficiency Syndrome
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/toward-precision-medicine-for-genetic-epilepsies-glucose-transporter-type-1-deficiency-syndrome/32055/As we begin to understand the mechanisms of specific genetic epilepsies, tailored treatments have the potential to be transformative, as in GLUT1-DS.Neuromuscular Amyloidosis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/neuromuscular-amyloidosis/31815/The most common amyloidosis are both treatable; accurate diagnosis is paramount.Friedreich Ataxia: Pathophysiology and Treatment
https://practicalneurology.com/diseases-diagnoses/movement-disorders/friedreich-ataxia-pathophysiology-and-treatment/32041/Great strides have been made in understanding the pathophysiology of Friedreich ataxia, and a variety of treatments are available, including the first drug approved for Friedreich ataxia treatment in 2023.Headache Horizons: Key Updates in Headache and Migraine Care
https://practicalneurology.com/diseases-diagnoses/headache-pain/key-updates-in-headache-and-migraine-care/35529/From gepants to GLP-1 agonists, new therapies and a shift toward early intervention may redefine migraine care and improve quality of life for people with migraine.